Challenging respiratory infections in cystic fibrosis.
Yousef
Abdullah A
AA
Jaffé
Adam
A
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000150:complications*; D005260:Female; D006801:Humans; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D009517:New South Wales / Q000453:epidemiology; D009170:Nontuberculous Mycobacteria / Q000187:drug effects / Q000302:isolation & purification; D011552:Pseudomonas Infections / Q000150:complications* / Q000453:epidemiology; D012141:Respiratory Tract Infections / Q000453:epidemiology / Q000209:etiology* / Q000382:microbiology
D000900:Anti-Bacterial Agents